Dr. Reddy's Laboratories (RDY) News Today $13.86 +0.25 (+1.82%) Closing price 02/4/2025 03:59 PM EasternExtended Trading$13.84 -0.02 (-0.13%) As of 04:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Caprock Group LLC Acquires 43,165 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Caprock Group LLC boosted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 280.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 58,563 shares of the company's stoFebruary 4 at 3:35 AM | marketbeat.comGreenleaf Trust Has $1.86 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Greenleaf Trust lifted its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 400.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 117,611 shares of the company'sFebruary 3 at 5:27 AM | marketbeat.comDr. Reddy's Lab: Near-Term Worries And Underappreciated Potential Could Lead To Huge ReturnsJanuary 30, 2025 | seekingalpha.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Bought by Hanson & Doremus Investment ManagementHanson & Doremus Investment Management grew its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 400.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 23,170 shares of the company's stock after purchasing an additional 18January 30, 2025 | marketbeat.comSmith Group Asset Management LLC Takes Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Smith Group Asset Management LLC purchased a new position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 43,400 shaJanuary 29, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Robeco Institutional Asset Management B.V.Robeco Institutional Asset Management B.V. lifted its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 453.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 11,438,908 shares of the company'sJanuary 29, 2025 | marketbeat.comDr. Reddy’s Laboratories Limited (NYSE:RDY) Q3 2025 Earnings Call TranscriptJanuary 28, 2025 | msn.comDr. Reddy's Laboratories (NYSE:RDY) Sets New 52-Week Low - Time to Sell?Dr. Reddy's Laboratories (NYSE:RDY) Sets New 12-Month Low - Should You Sell?January 27, 2025 | marketbeat.comDGS Capital Management LLC Increases Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)DGS Capital Management LLC boosted its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 528.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 74,993 shares of the company's stockJanuary 25, 2025 | marketbeat.comIndian drugmaker Dr Reddy's shares slide after Q3 profit missJanuary 24, 2025 | msn.comDr. Reddy's Laboratories Limited 2025 Q3 - Results - Earnings Call PresentationJanuary 24, 2025 | seekingalpha.comLifestyle Asset Management Inc. Buys 57,799 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)Lifestyle Asset Management Inc. raised its stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 422.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 71,488 shares of the company's stock after purchasing an additionJanuary 24, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (RDY) Q3 2025 Earnings Call TranscriptJanuary 23, 2025 | seekingalpha.comDr. Reddy's Laboratories (NYSE:RDY) Stock Price Down 5.5% - Here's WhyDr. Reddy's Laboratories (NYSE:RDY) Shares Down 5.5% - Here's What HappenedJanuary 23, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Announces Quarterly Earnings ResultsDr. Reddy's Laboratories (NYSE:RDY - Get Free Report) announced its quarterly earnings data on Thursday. The company reported $0.20 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.19 by $0.01. Dr. Reddy's Laboratories had a net margin of 17.81% and a return on equity of 18.53%.January 23, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Issues Quarterly Earnings ResultsDr. Reddy's Laboratories (NYSE:RDY - Get Free Report) posted its quarterly earnings data on Thursday. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.19 by $0.01. Dr. Reddy's Laboratories had a net margin of 17.81% and a return on equity of 18.53%.January 23, 2025 | marketbeat.comDr. Reddy's Q3 & 9MFY25 Financial ResultsJanuary 23, 2025 | businesswire.comCLSA lowers Dr. Reddy's shares price target, citing lack of near-term growth triggersJanuary 23, 2025 | msn.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Acquired by Ballentine Partners LLCBallentine Partners LLC increased its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 577.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 104,715 shares of the company's stock afterJanuary 22, 2025 | marketbeat.comDr. Reddy's Laboratories (RDY) Expected to Announce Quarterly Earnings on WednesdayDr. Reddy's Laboratories (NYSE:RDY) will be releasing earnings on Wednesday, January 29, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=656418)January 22, 2025 | marketbeat.comBridgewater Advisors Inc. Takes Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Bridgewater Advisors Inc. purchased a new stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 31,093 shares of the company's stock, valued at approximateJanuary 20, 2025 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Bought by Artemis Investment Management LLPArtemis Investment Management LLP lifted its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 398.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 295,530 shares of the company's stockJanuary 20, 2025 | marketbeat.comRitholtz Wealth Management Has $1.27 Million Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)Ritholtz Wealth Management raised its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 362.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 80,595 shares of the company's stock after purchasing an additionalJanuary 19, 2025 | marketbeat.comDr. Reddy’s Laboratories Ltd ADRJanuary 16, 2025 | 247wallst.comDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Down - Time to Sell?Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Down - What's Next?January 16, 2025 | marketbeat.comDr. Reddy's Laboratories rises Wednesday, still underperforms marketJanuary 15, 2025 | marketwatch.comNordea Investment Management AB Grows Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)Nordea Investment Management AB boosted its holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 441.8% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 125,363 shares of the company's stock after acquiring an additJanuary 12, 2025 | marketbeat.comJPMorgan Chase & Co. Has $39.78 Million Stock Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY)JPMorgan Chase & Co. decreased its position in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 21.6% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 500,723 shares of the company's stock after selling 138,035 shares during theJanuary 6, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Shares Pass Above Two Hundred Day Moving Average - What's Next?Dr. Reddy's Laboratories (NYSE:RDY) Share Price Passes Above 200-Day Moving Average - What's Next?January 4, 2025 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - What's Next?Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Still a Buy?December 27, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Here's What HappenedDr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Here's WhyDecember 20, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Trading 4.7% Higher - Should You Buy?Dr. Reddy's Laboratories (NYSE:RDY) Trading Up 4.7% - Time to Buy?December 19, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Stock Rating Lowered by NomuraNomura cut shares of Dr. Reddy's Laboratories from a "buy" rating to a "neutral" rating in a research note on Thursday.December 19, 2024 | marketbeat.comNational Bank of Canada FI Sells 180,921 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)National Bank of Canada FI trimmed its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 98.3% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,199 shares of the company's stock after sellDecember 17, 2024 | marketbeat.comWorld Investment Advisors LLC Makes New $3.46 Million Investment in Dr. Reddy's Laboratories Limited (NYSE:RDY)World Investment Advisors LLC bought a new stake in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 43,539 shares of the company's stock, valued at approximatelDecember 14, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (NYSE:RDY) Shares Sold by Jane Street Group LLCJane Street Group LLC cut its position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 34.1% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 192,189 shares of the company's stock after selling 99,620 shares during theDecember 13, 2024 | marketbeat.comDr. Reddy's Laboratories (NYSE:RDY) Lowered to Hold Rating by StockNews.comStockNews.com lowered Dr. Reddy's Laboratories from a "buy" rating to a "hold" rating in a research report on Friday.December 6, 2024 | marketbeat.comDr. Reddy’s Boosts Workforce with Equity AllotmentDecember 3, 2024 | markets.businessinsider.comDr. Reddy's Launches Toripalimab For Nasopharyngeal Carcinoma In IndiaNovember 28, 2024 | markets.businessinsider.comWhat is Zacks Research's Forecast for RDY FY2025 Earnings?Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) - Stock analysts at Zacks Research upped their FY2025 earnings per share (EPS) estimates for Dr. Reddy's Laboratories in a research report issued on Tuesday, November 26th. Zacks Research analyst R. Department now expects that the companyNovember 28, 2024 | marketbeat.comDr. Reddy’s Fined in Germany for Registration LapseNovember 28, 2024 | markets.businessinsider.comDr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinomaNovember 28, 2024 | businesswire.comDr. Reddy’s and Senores launch Ivermectin tablets USP, 3 mg in U.S.November 26, 2024 | markets.businessinsider.comDr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. Announce the Launch of Ivermectin Tablets USP, 3 mg in US MarketNovember 26, 2024 | businesswire.comDr. Reddy’s Gains Strong Rating Amid Robust GrowthNovember 20, 2024 | markets.businessinsider.comDr. Reddy’s Laboratories Reports Record Quarterly GrowthNovember 13, 2024 | markets.businessinsider.comDr. Reddy's Laboratories (NYSE:RDY) Downgraded to Buy Rating by StockNews.comStockNews.com cut Dr. Reddy's Laboratories from a "strong-buy" rating to a "buy" rating in a report on Wednesday.November 13, 2024 | marketbeat.comDr. Reddy’s to Engage with Investors in MumbaiNovember 7, 2024 | markets.businessinsider.comBarclays Lowers Dr. Reddy's Laboratories (NYSE:RDY) Price Target to $17.00Barclays cut their target price on Dr. Reddy's Laboratories from $17.40 to $17.00 and set an "overweight" rating for the company in a research note on Wednesday.November 6, 2024 | marketbeat.comDr. Reddy's Laboratories Limited (RDY) Q2 2025 Earnings Call TranscriptNovember 5, 2024 | seekingalpha.com Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address RDY Media Mentions By Week RDY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDY News Sentiment▼0.940.44▲Average Medical News Sentiment RDY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDY Articles This Week▼63▲RDY Articles Average Week Get Dr. Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for RDY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Takeda Pharmaceutical News argenx News BioNTech News Teva Pharmaceutical Industries News BeiGene News Summit Therapeutics News Moderna News Intra-Cellular Therapies News Viatris News Genmab A/S News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RDY) was last updated on 2/5/2025 by MarketBeat.com Staff From Our PartnersNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHe called the top and bottom of Bitcoin nearly to the day … Here’s what he says is next.With Donald Trump’s return to the oval office, the war on crypto is over. The digital currency is not only ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNew crypto boom will be greatest in historyUrgent Notice from Ian King, the Crypto Expert Who Made 18,325% in a Year: “Donald Trump’s second term is t...Banyan Hill Publishing | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Reddy's Laboratories Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
